Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Explore ways to hold yourself accountable to a budget for better financial management. Stay responsible and achieve your financial goals!
15,890 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
President Trump signals possible limited military action against Iran as nuclear talks proceed, a move that could res...
A late 2025 study finds workers would sacrifice up to a quarter of compensation to keep remote work options. The resu...
When a large investor makes a bold move, the spotlight shifts from fundamentals to signals. This article unpacks how ...
Tech-heavy Nasdaq faces renewed pressure as crude prices push above $100 a barrel. Traders weigh how energy inflation...
Northrop Grumman shares are rising on a new Air Force contract to speed up B-21 production, signaling upside not yet ...
A cliff-like Medicare IRMAA rule makes a tiny annual income step cost retirees hundreds more each month. This report ...
You don't need a fortune to start building a durable, growth-oriented portfolio. With $300, you can own three high-qu...
As drone-saturated battlefields rise, the world’s most advanced tanks drive a new era of defense spending. This repor...
A clear, investor-friendly breakdown of Primoris' Q1 2026 earnings. Learn what drove results, how to read backlog and...
A landmark decision reshapes the Fed’s usual leadership path. This article breaks down what happened, why it matters ...
Explore Innoviz's path in 2026 with a deep dive into Q1 results, margins, backlog, and strategic bets. This analysis ...